Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
Innate drops monotherapy plans for lacutamab in type of lymphoma
Two months after the FDA lifted a hold on Innate's lymphoma drug, the biotech drops plans for the antibody as a monotherapy for a form of that cancer.
James Waldron
Mar 21, 2024 8:27am
Nurix gets BTK degrader back on track after FDA lifts hold
Mar 11, 2024 9:25am
FDA lifts hold on Iovance's lung cancer cell therapy trial
Mar 4, 2024 9:44am
CytoDyn finally clears FDA hold on HIV program after 2 years
Feb 29, 2024 10:20am
Rapt faces clinical hold after liver failure in immunology trial
Feb 20, 2024 10:42am
Gilead pauses CD47 solid tumor trials as FDA seeks partial hold
Feb 16, 2024 6:45am